LFMDP News and Press, LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock From 02/15/24

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced that management will be participating in three upcoming investor conferences and a webinar discussing GLP-1s. D.A. Davidson GLP-1 Webinar, Feb...

2024-02-10 22:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11 th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, being held February 13-14, 2024 at t...

2024-01-20 08:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Conference, being held January 24-25, 2024. Management will participate in a virtual firesid...

2024-01-11 16:49:58 ET Summary LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct marketing its GLP-1 obesity drugs. These fears are...

Revenue expected to be between $195 and $205 million, represents a 31% to 38% increase over the midpoint of 2023 guidance. Adjusted EBITDA expected to be between $18 and $22 million, representing an increase of 71% to 110% over the midpoint of 2023 guidance. Positive full-year free cash...

2024-01-03 15:59:48 ET More on LifeMD, Inc. 8.875% CUM PFD A LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds LifeMD, Inc. (LFMD) Q3 2023 Earnings Call Transcript LifeMD, Inc. 2023 Q3 - Results - Earnings Call Presentation Historical earnings dat...

2023-12-26 16:15:54 ET More on LifeMD, Inc. 8.875% CUM PFD A LifeMD: My Tech Pick For 2024 And Its 12% Yielding Preferreds LifeMD, Inc. (LFMD) Q3 2023 Earnings Call Transcript LifeMD, Inc. 2023 Q3 - Results - Earnings Call Presentation Historical earnings dat...

2023-12-17 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...